ADAG Adagene Inc.

NASDAQ
$2.93

Adagene Inc. (ADAG) is expected to report earnings on August 12, 2026, before the market open. The consensus earnings estimate is a loss of $0.08 per share.

Earnings Date
3rd Quarter, Sep 2026
Aug 12
Wednesday · Before Open
Earnings Whisper
-
vs ($0.08)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Adagene Inc.

Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene Inc. is based in SAN FRANCISCO, Calif.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.